ACTIVE

Kerckaert Pharma

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
134,1 k €
+11,1 %over 1 year
Gross margin
191,9 k €
+7,2 %over 1 year
Equity
37,1 k €
+32,3 %over 1 year
Workforce
0,8 ETP
0,0 %over 1 year

Identity

Source · BCE/KBO

Kerckaert Pharma is a Private limited company incorporated in 2015. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Lievegem. It employs on average 0,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0645.736.522
Incorporation
30/12/2015
Legal form
Private limited company
Registered office
Molendreef 10
9920 Lievegem · FlandreSee on map
Contributed capital
18 550,00 €
Latest accounts
31/12/2025
Average workforce
0,8 ETP
Joint committees (2)
  • 313
  • 3130
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 10 filings

Trend over 9 financial years

20252024202320222021
Income statement
Gross margin191,9 k €179 k €104,9 k €-62,7 k €161,6 k €
EBITDA147,6 k €135,1 k €92,2 k €-53,2 k €20,6 k €
Operating result139 k €126,6 k €84,5 k €-59,1 k €18,7 k €
Net result134,1 k €120,7 k €80,9 k €-64,7 k €8,5 k €
Balance sheet
Equity37,1 k €28,1 k €17,4 k €-43,5 k €21,3 k €
Total assets350,3 k €295,6 k €274,7 k €297,2 k €328,5 k €
Cash87,6 k €35,5 k €36,5 k €32,1 k €89,5 k €
Debts312,8 k €267,3 k €257,1 k €340,6 k €307,2 k €
Other
Workforce0,8 ETP0,8 ETP0,2 ETP0,0 ETP2,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 16 ended

Active mandates

TINE KERCKAERT

Director · since 27 décembre 2022 · 0734.563.776

Represented by Kerckaert Tine

Active

Ended mandates

APRIVO

Director · since 30 avril 2021 · 0845.171.490

Represented by Van GANSBEKE STEVEN

Ended
Barbara Vanderstichele

Director · since 30 décembre 2015 · until 30 avril 2021

Ended
Barbara Vanderstichele

Director · since 30 décembre 2015

Ended
Ilse Vanderstichele

Director · since 30 décembre 2015 · until 30 avril 2021

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date13/07/202630/08/202528/08/202429/08/202328/07/202230/04/2021
General meeting26/06/202627/06/202528/06/202430/06/202326/07/202221/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 10 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/06/202613/07/2026DutchPDF
Abridged model31/12/202427/06/202530/08/2025DutchPDF
Abridged model31/12/202328/06/202428/08/2024DutchPDF
Abridged model31/12/202230/06/202329/08/2023DutchPDF
Abridged model31/12/202126/07/202228/07/2022DutchPDF
Abridged model31/12/202021/04/202130/04/2021DutchPDF
Micro model31/12/201915/05/202013/07/2020DutchPDF
Micro model31/12/201824/06/201930/07/2019DutchPDF
Micro model31/12/201725/06/201816/07/2018DutchPDF
Micro model31/12/201630/06/201731/07/2017DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 16 ended

Active mandates

TINE KERCKAERT

Director · since 27 décembre 2022 · 0734.563.776

Represented by Kerckaert Tine

Active

Ended mandates

APRIVO

Director · since 30 avril 2021 · 0845.171.490

Represented by Van GANSBEKE STEVEN

Ended
Barbara Vanderstichele

Director · since 30 décembre 2015 · until 30 avril 2021

Ended
Barbara Vanderstichele

Director · since 30 décembre 2015

Ended
Ilse Vanderstichele

Director · since 30 décembre 2015 · until 30 avril 2021

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates06/02/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Mandates10/06/2021
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/11/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other19/01/2016
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025134,1 k €↑
  2. 2024
    Annual accounts 2024120,7 k €↑
  3. 2023
    Annual accounts 202380,9 k €↑
  4. 2022
    Annual accounts 2022-64,7 k €↓
  5. 2022
    Name changeKerckaert Pharma
  6. 2021
    Annual accounts 20218,5 k €↓
  7. 2021
    Name changeApotheek Vanderstichele
  8. 2020
    Annual accounts 202018,1 k €↑
  9. 2019
    Annual accounts 20192,3 k €↓
  10. 2018
    Annual accounts 201829,7 k €↑
  11. 2017
    Annual accounts 201725,2 k €
  12. 30/12/2015
    IncorporationPrivate limited company